| Name | Safeway Pharmacy #1684 |
|---|---|
| Organization Name | Safeway Inc |
| Location | 1940 E Broadway Rd, Tucson, Arizona 85719 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (520) 206-9052 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Researchers long have known that some portion of the risk of developing cancer is hereditary and that inherited genetic errors are very important in some tumors but much less so in others.
Research by a team of Vanderbilt University Medical Center scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer's pathology first begins.
Researchers say these findings highlight the need for improved diagnosis and treatment of sleep disorders in mild traumatic brain injury patients who complain of insomnia.
Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, presented new data at the MIT Center for Biomedical Innovation's Biomanufacturing Summit from its platform efforts aimed at developing RNAi technologies for applications in biologics manufacturing.
The German Lung Cancer Screening Intervention Trial shows that the early repeat scan rate for suspicious findings decreased by more than 80% with the second and subsequent low-dose computed tomography (LDCT) screens, but emphasizes the need to have an organized screening program with the baseline scan available for comparison.
› Verified 6 days ago
| NPI Number | 1770642878 |
| Organization Name | SAFEWAY INC |
| Doing Business As | SAFEWAY PHARMACY #1684 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1940 E Broadway Blvd, Tucson, AZ 85719 |
| Phone Number | 520-206-9052 |
News Archive
Researchers long have known that some portion of the risk of developing cancer is hereditary and that inherited genetic errors are very important in some tumors but much less so in others.
Research by a team of Vanderbilt University Medical Center scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer's pathology first begins.
Researchers say these findings highlight the need for improved diagnosis and treatment of sleep disorders in mild traumatic brain injury patients who complain of insomnia.
Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, presented new data at the MIT Center for Biomedical Innovation's Biomanufacturing Summit from its platform efforts aimed at developing RNAi technologies for applications in biologics manufacturing.
The German Lung Cancer Screening Intervention Trial shows that the early repeat scan rate for suspicious findings decreased by more than 80% with the second and subsequent low-dose computed tomography (LDCT) screens, but emphasizes the need to have an organized screening program with the baseline scan available for comparison.
› Verified 6 days ago
News Archive
Researchers long have known that some portion of the risk of developing cancer is hereditary and that inherited genetic errors are very important in some tumors but much less so in others.
Research by a team of Vanderbilt University Medical Center scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer's pathology first begins.
Researchers say these findings highlight the need for improved diagnosis and treatment of sleep disorders in mild traumatic brain injury patients who complain of insomnia.
Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, presented new data at the MIT Center for Biomedical Innovation's Biomanufacturing Summit from its platform efforts aimed at developing RNAi technologies for applications in biologics manufacturing.
The German Lung Cancer Screening Intervention Trial shows that the early repeat scan rate for suspicious findings decreased by more than 80% with the second and subsequent low-dose computed tomography (LDCT) screens, but emphasizes the need to have an organized screening program with the baseline scan available for comparison.
› Verified 6 days ago
Act Now Dme Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7620 N Hartman Ln, Tucson, Arizona 85743 Phone: (520) 422-2411 | |
Osco Drug #0960 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7300 N La Cholla Blvd, Tucson, Arizona 85741 Phone: (520) 575-0662 | |
Osco Drug #0963 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6600 E Grant Rd, Tucson, Arizona 85715 Phone: (520) 885-9192 | |
Osco Drug #2988 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5085 N La Canada Dr, Tucson, Arizona 85704 Phone: (520) 696-0346 | |
Osco Drug #3964 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9595 E Broadway Blvd, Tucson, Arizona 85748 Phone: (520) 751-7549 |